May 17, 2022

Duopharma Biotech Posts Improved 1Q 2022 Performance

● 1Q 2022 PBT increased by 15% to RM26.65 million compared to previous corresponding quarter
● Revenue gained 12% to RM185.94 million year-on-year
● Improving Malaysian economy, recovery in domestic demand bode well for Duopharma Biotech’s prospects